haylaavo

J B CHEMICALS AND PHARMA

JBCHEPHARM · NSE · inactive
2,408.90
-97.10 (-3.87%)
as of 16 Jul 2026 close
Open
2,506.00
High
2,525.50
Low
2,380.00
Prev close
2,506.00
52w high
2,525.50
16 Jul 2026
52w low
1,638.50
26 Sept 2025
VWAP
2,418.56
Delivery %
66.8%
of volume
Volume 47.79 L · turnover ₹1155.88 Cr · NSE bhavcopy (official close), adjusted for splits/bonuses · history since 02 Feb 1995
Series
EQ
F&O
No
Status
Inactive since 17 Jul 2026

Source: NSE equity master · as of 16 Jul 2026

Market cap
—
P/B
—
ROE (TTM)
17.1%
ROCE 23.0%
Debt / equity
0.00
P/E (TTM)
—
P/S (TTM)
—
Revenue TTM
₹4,148 cr
Net profit TTM
₹709 cr
Net margin TTM
17.1%
OPM 26.0%
EV / EBITDA
—
Interest cover
172.0×
Revenue growth
-4.8%
latest quarter YoY
Profit growth
-30.4%
latest quarter YoY
Dividend yield
—
₹22 / share · payout —

Consolidated · last four quarters to 2026-03-31 · balance sheet 2026-03-31 · tap a tile for the formula

Daily · NSE EOD
Exchange announcements
Source: NSE corporate filings · latest Today 21:45 IST
AllM&AAGM / meetingAnalyst meetBoard meetingBusiness updateManagementComplianceCorporate actionCredit ratingDividendExchange queryGeneral updateInsider / SASTLegalOrder winResults
  • 31 Aug 2025 11:07
    Management

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Cessation of Ms Padmini Khare Kaicker as Non- Executive Independent Director of the company w.e.f. August 30, 2025.

    PDF · 333.42 KB
  • 14 Aug 2025 13:35
    Insider / SAST

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Allotment of 114999 Shares.

    PDF · 630.64 KB
  • 11 Aug 2025 16:34
    Insider / SAST

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Allotment of 23003 Shares.

    PDF · 3.54 MB
  • 06 Aug 2025 22:14
    AGM / meeting

    JB Chemicals & Pharmaceuticals Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 06, 2025. Further, the company has informed the Exchange regarding voting results.

    PDF · 12.29 MB
  • 06 Aug 2025 20:01
    Management

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Change in Auditors of the company.

    PDF · 3.55 MB
  • 06 Aug 2025 20:01
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Change in Registered Office

    PDF · 3.53 MB
  • 06 Aug 2025 20:01
    Management

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Change in Auditors of the company.

    PDF · 3.55 MB
  • 06 Aug 2025 19:55
    Management

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Appointment of Mr Nikhil Chopra as Executive Director of the company w.e.f. October 05, 2025.

    PDF · 3.56 MB
  • 06 Aug 2025 19:55
    Management

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Appointment of Mr Sumit Bose as Independent Director of the company w.e.f. August 31, 2025.

    PDF · 3.55 MB
  • 06 Aug 2025 19:51
    Management

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Appointment of Mr Ashwani Kumar Puri as Independent Director of the company w.e.f. May 14, 2025.

    PDF · 3.54 MB
  • 06 Aug 2025 19:51
    Management

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Appointment of Ms Richa Arora as Independent Director of the company w.e.f. July 10, 2025.

    PDF · 3.55 MB
  • 06 Aug 2025 19:27
    AGM / meeting

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 06, 2025

    PDF · 3.54 MB
  • 05 Aug 2025 19:21
    Analyst meet

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Transcript

    PDF · 3.75 MB
  • 31 Jul 2025 17:39
    Compliance

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Newspaper Newspaper advertisement pertaining to financial results for quarter ended on June 30, 2025

    PDF · 5.54 MB
  • 31 Jul 2025 17:39
    Analyst meet

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Link of Recording

    PDF · 635.24 KB
  • 30 Jul 2025 18:13
    Business update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 30, 2025, titled "Press Release".

    PDF · 1.01 MB
  • 30 Jul 2025 18:13
    Analyst meet

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation

    PDF · 2.20 MB
  • 30 Jul 2025 18:09
    Board meeting

    JB Chemicals & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.

    PDF · 6.91 MB
  • 23 Jul 2025 18:26
    Analyst meet

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Schedule of meet

    PDF · 764.46 KB
  • 22 Jul 2025 18:36
    Corporate action

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding allotment of 259077 securities pursuant to ESOP/ESPS at its meeting held on July 22, 2025

    PDF · 633.76 KB
  • 17 Jul 2025 19:37
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'Letter To Shareholders - Integrated Annual Report FY 2024-25'.

    PDF · 1.14 MB
  • 17 Jul 2025 19:19
    Compliance

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

    PDF · 687.80 KB
  • 12 Jul 2025 14:40
    Compliance

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper advertisement

    PDF · 9.18 MB
  • 11 Jul 2025 19:48
    Corporate action

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Final Dividend 2024-25 is 30-Jul-2025.

    PDF · 623.97 KB
  • 11 Jul 2025 18:52
    AGM / meeting

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 06, 2025

    PDF · 994.72 KB
  • 10 Jul 2025 18:25
    Management

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Appointment of Ms Richa Arora as Non- Executive Independent Director of the company w.e.f. July 10, 2025.

    PDF · 642.66 KB
  • 04 Jul 2025 17:48
    Compliance

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Newspaper Publication of Detailed Public Statement in connection with the open offer

    PDF · 17.04 MB
  • 04 Jul 2025 15:42
    Corporate action

    NovaaOne Capital Private Ltd has submitted to  the Exchange a copy of Detailed public statement in terms of Regulations 3(1) and 4 Read with Regulations 13(4), 14 (3) and 15(2) and other applicable regulations of the securities and Exchange Board of India (SAST) Regulations, 2011 , as amended, to the eligible shareholders  ( as defined below) of the company.

    PDF · 16.53 MB
  • 30 Jun 2025 16:11
    Corporate action

    NovaaOne Capital Private Ltd has submitted to  the Exchange a copy of Public announcement under Regulation 3(1) and 4 Read with Regulations 13(1), 14 and 15(1) of the securities and exchange Board of India ( SAST) Regulations, 2011 as amended.

    PDF · 493.78 KB
  • 30 Jun 2025 13:33
    Analyst meet

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Investor Presentation

    PDF · 1.65 MB
  • 30 Jun 2025 08:00
    Corporate action

    NovaaOne Capital Private Limited has submitted to the Exchange a copy of Public Announcement - Open Offer for J.B. Chemicals & Pharmaceuticals Ltd. (the Target Company ) under Regulation 3 (1) and 4 read with Regulations 13(1), 14 and 15 (1) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 as amended

    PDF · 493.78 KB
  • 30 Jun 2025 24:56
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Public Announcement of open offer for acquisition of Company s equity shares

    PDF · 941.59 KB
  • 29 Jun 2025 20:18
    M&A

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Amalgamation/Merger

    PDF · 809.81 KB
  • 29 Jun 2025 20:00
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Change of Registered Office

    PDF · 713.06 KB
  • 29 Jun 2025 19:50
    Business update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 29, 2025, titled "Press Release".

    PDF · 1.11 MB
  • 28 Jun 2025 19:54
    Management

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Appointment of Mr Nikhil Ashokkumar Chopra as Chief Executive Officer of the company w.e.f. October 05, 2025.

    PDF · 3.66 MB
  • 27 Jun 2025 23:52
    Compliance

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

    PDF · 3.52 MB
  • 24 Jun 2025 18:26
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding 'ANDA Approval by US FDA'.

    PDF · 3.51 MB
  • 18 Jun 2025 13:07
    Compliance

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication

    PDF · 7.31 MB
  • 17 Jun 2025 17:41
    Compliance

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Prior Public Notice for Equity Shareholders of the Company with regard to convening of AGM through Video Conferencing (VC)/Other Audio Visual Means (OAVM).

    PDF · 6.33 MB
  • 16 Jun 2025 17:46
    Analyst meet

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Schedule of meet

    PDF · 716.81 KB
  • 11 Jun 2025 17:59
    Insider / SAST

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding of 85390 Options.

    PDF · 633.63 KB
  • 05 Jun 2025 11:44
    Insider / SAST

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Allotment of 112990 Shares.

    PDF · 629.29 KB
  • 25 May 2025 16:59
    Insider / SAST

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Allotment of 75180 Shares.

    PDF · 627.26 KB
  • 20 May 2025 12:37
    Insider / SAST

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Allotment of 42470 Shares.

    PDF · 629.24 KB
  • 20 May 2025 12:35
    Analyst meet

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Transcript

    PDF · 804.32 KB
  • 15 May 2025 16:56
    Analyst meet

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Link of Recording

    PDF · -
  • 15 May 2025 16:56
    Compliance

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper advertisement pertaining to financial results for quarter and year ended on March 31, 2025

    PDF · -
  • 14 May 2025 20:25
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Appointment of Secretarial Auditor

    PDF · -
  • 14 May 2025 20:25
    General update

    JB Chemicals & Pharmaceuticals Limited has informed the Exchange about re-appointment of Statutory Auditor

    PDF · -
Older announcements →
Coming next in news
Arrives in Phase 3. Nothing here is estimated or filled in — we only show data we have.
  • Results & board-meeting calendar
  • Dividend, split, AGM calendar
  • Headlines with source and timestamp
  • Two-line factual filing summaries